Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse
- 1 June 1989
- journal article
- research article
- Published by Springer Nature in Molecular and Chemical Neuropathology
- Vol. 10 (3) , 171-183
- https://doi.org/10.1007/bf03159727
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brainJournal of the Neurological Sciences, 1987
- Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeysAnnals of Neurology, 1986
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to NeuromelaninScience, 1986
- Positron emission tomography after MPTP: observations relating to the cause of Parkinson's diseaseNature, 1985
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the ratEuropean Journal of Pharmacology, 1984
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979